What is the ideal time to perform a congenital anomaly scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ideal Time for Congenital Anomaly Scanning

The ideal time to perform a congenital anomaly scan is between 18 and 20 weeks of gestation for low-risk pregnancies, as recommended by the multi-specialty consensus panel from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. 1

Standard Timing for Low-Risk Pregnancies

For routine screening in low-risk pregnancies, at least one ultrasound should be offered routinely to all pregnant women between 18 and 20 weeks of gestation 1. This timing represents the optimal balance between:

  • Adequate fetal development for visualization of anatomical structures
  • Early enough detection to allow for informed decision-making
  • Sufficient time before viability concerns complicate management options

The components of this standard fetal examination have been agreed upon by multiple organizations including ACR-ACOG-AIUM-SMFM-SRU 1.

Modified Timing for Special Populations

Obese Patients

For obese women, the anatomic survey should be performed at 20 to 22 weeks (approximately 2 weeks later than standard timing) 1. This is critical because:

  • Obese patients have increased rates of congenital anomalies (neural tube defects, cardiovascular anomalies, cleft lip/palate, anorectal atresia, hydrocephaly, limb reduction anomalies) 1
  • Suboptimal visualization occurs with increasing body mass index 1
  • If the scan is incomplete, repeat follow-up ultrasound should be performed in 2 to 4 weeks 1

Emerging evidence supports adding early transvaginal imaging at 12-16 weeks in obese women, combined with the routine transabdominal study at 18-22 weeks, which achieves completion rates comparable to non-obese populations 1.

High-Risk Pregnancies

For high-risk pregnancies (maternal age, IVF use, drug dependence, infection, maternal medical conditions, family history of genetic disease, multi-gestational pregnancies, teen pregnancies, abnormal screening tests), a detailed fetal anatomic examination should be performed, though the specific timing follows similar principles to low-risk pregnancies 1.

First-Trimester Scanning: Complementary Role

While not replacing the standard 18-20 week scan, first-trimester scanning at 11-14 weeks can detect approximately 37.5% of structural anomalies overall but 91.3% of lethal anomalies 2. Recent evidence shows:

  • First-trimester scans detect 93.3% of eight major pre-selected anomalies with 99.99% specificity 3
  • Particularly severe anomalies (neural tube defects, omphalocele, megacystis, multiple severe congenital anomalies) are amenable to early diagnosis 4
  • Cardiac anomaly detection is lower at first trimester (55.8% sensitivity) 3

Two-stage screening (first trimester plus second trimester) achieves 83.8% sensitivity compared to 50.5% for single-stage second-trimester screening alone 2, though this comes with additional cost and resource utilization.

Third-Trimester Considerations

Routine third-trimester screening is not recommended for low-risk pregnancies, as large trials showed no evidence of improved antenatal, obstetric, or neonatal outcomes 1. However, approximately 15% of anomalies may only be detected in the third trimester, making it useful for:

  • Late arrivals to prenatal care
  • Follow-up of known anomalies
  • Perinatal management planning 1

Common Pitfalls to Avoid

  1. Do not abandon the 18-20 week scan even if first-trimester scanning is performed - many anomalies present at varying gestational ages and some cardiac defects are not visible until later 5

  2. Do not delay scanning beyond 22 weeks in obese patients without attempting earlier visualization - consider transvaginal approach if transabdominal views are inadequate 1

  3. Do not assume complete evaluation is possible at 11-14 weeks - completion rates for first-trimester anatomy are approximately 49-60% even in experienced centers 6, 4

Practical Algorithm

For standard practice:

  • Low-risk patients: Single scan at 18-20 weeks
  • Obese patients: Scan at 20-22 weeks (consider early transvaginal at 12-16 weeks if available)
  • High-risk patients: Consider two-stage approach (11-14 weeks + 18-20 weeks) for increased detection rates

If fetal MRI is needed for incomplete ultrasound findings, perform at or after 22 weeks gestation 1, though 18-22 weeks may be valuable in certain clinical settings.

References

Guideline

acr appropriateness criteria® second and third trimester screening for fetal anomaly.

Journal of the American College of Radiology, 2021

Research

Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2018

Research

Early fetal anomaly scanning in a population at increased risk of abnormalities.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2002

Related Questions

Should a face not visualized on a routine mid‑trimester anomaly scan be followed up with a repeat detailed ultrasound?
What test should be done at 6 weeks gestation?
What are the various types of antenatal ultrasound examinations and their appropriate timing and indications during pregnancy?
What are the chances of no fetal heartbeat at the 12-week scan after a healthy 6-week scan with a normal fetal heart rate?
What are the 2025 ACC/AHA guideline recommendations for blood pressure targets, lipid management, heart failure therapy, post‑myocardial infarction secondary prevention, stable coronary artery disease, and atrial fibrillation anticoagulation in adults?
In a postmenopausal woman, is hormone replacement therapy still effective if initiated beyond the recommended window (more than 10 years after menopause or after age 60)?
What are the typical symptoms of post‑viral reactive airway disease?
What is the typical severity of flank pain in acute pyelonephritis?
What G6PD‑safe oral antibiotic and dosing regimen should be used for a 18.4 kg child with a urinary tract infection?
In a known lymphoma patient with persistent fever and a CBC showing hemoglobin 10 g/dL, RBC count 4.01 ×10⁶/µL, hematocrit 32 %, MCV 80 fL, MCHC 31.15 g/dL, RDW 15.5 %, neutrophils 80 % and lymphocytes 15 %, how should these findings be interpreted and what management steps are recommended?
Is it safe for a generally healthy adult without known liver disease to take the liver‑support supplement Hepatosafe?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.